Therapeutic drug monitoring of antiepileptic drugs by use of saliva.
about
On the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug MonitoringUnnecessary Investigations in Environmental MedicineClinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsyPrimidone inhibits TRPM3 and attenuates thermal nociception in vivoUtility of noninvasive biomatrices in pharmacokinetic studies.Hyperammonemia associated with valproic acid concentrations.Development and validation of a reversed-phase HPLC method for licarbazepine monitoring in serum of patients under oxcarbazepine treatment.In vivo Raman measurement of levofloxacin lactate in blood using a nanoparticle-coated optical fiber probe.Advances in epilepsy treatment: lacosamide pharmacokinetic profile.Current advances in biosampling for therapeutic drug monitoring of psychiatric CNS drugs.A Qualitative Review on the Pharmacokinetics of Antibiotics in Saliva: Implications on Clinical Pharmacokinetic Monitoring in Humans.Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: A comparison of free non-protein-bound concentrations.Determination of serum carbamazepine concentration using dried blood spot specimens for resource-limited settings.Pharmacotherapy in pediatric epilepsy: from trial and error to rational drug and dose selection - a long way to go.Urine and oral fluid drug testing in support of pain management.Therapeutic drug monitoring in the era of precision medicine: opportunities!Human saliva-based quantitative monitoring of clarithromycin by flow injection chemiluminescence analysis: a pharmacokinetic study.Revolutionizing Therapeutic Drug Monitoring with the Use of Interstitial Fluid and Microneedles Technology.Individualized Dosing Algorithms and Therapeutic Monitoring for Antiepileptic Drugs.A LC-MS/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS.A descriptive systematic review of salivary TDM in neonates and infants.Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines.Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole.Noninvasive Sampling of Gabapentin by Reverse IontophoresisQuantification of valproic acid in dried blood spots
P2860
Q27024074-7B388F7A-84EE-4478-B3EA-9404C452A1DDQ28396815-E3C0175F-D0F6-4B3B-ACF7-0DBE18228D46Q28543246-51900AC4-09CF-4D07-9A26-82814DF996ACQ30846820-9F6ED6BB-A8BC-471E-989F-A6C0D76189B4Q31126290-B66C1374-93BB-4957-BACA-28A17E47EA5DQ33608984-B81C7A9E-EBAE-4310-A342-73F4F5D57412Q36275095-FA49E467-CD46-4F61-9EFD-DADCE7C2842BQ36899684-5C4A1C0E-167A-457E-B252-BCAD3532B701Q38244248-9D9C9F97-6E88-431C-BA98-5C0D2F0AF55CQ38571074-1517DEA9-8255-4017-8CDF-83FAA437F2EDQ38582536-5E606164-D353-4590-BEB1-8ACC07B25B17Q38764753-62BB107F-2F7E-405F-8756-4C52385D5A15Q38869456-0F461DCF-4725-4BBF-9D7B-1A1271D9E6E0Q38902279-B0166EB7-B8B0-4E13-8D54-168DA7829A80Q41989786-7CFC525B-C6B1-415C-8759-456813B54309Q42358633-7E1F44C6-68AF-4749-BB42-DA17FE7CB40AQ44233342-4A2DE9BE-0C49-4B61-B8EE-A3975F5D9EF3Q47580223-C900540E-88C2-4CC3-8002-4B722C21AC7EQ47786666-650F5DFB-A778-438D-9477-76D54C8C6CBEQ48017263-BDF038D1-2EDF-4B0B-B73E-AD4DFF5C3FAEQ50016064-176864F5-D5C7-4EF6-9FD4-4988B24860D3Q50290626-44B40632-E3DC-410B-8759-D4B1A1C6814EQ53171412-6C16A8EE-C70C-4DDA-BF27-526C78C84798Q56035503-43C403A3-65B3-4A08-8F34-23B4D8AFD72BQ56828522-4D066F8D-3B7C-4C99-BD51-A8C68FA0259A
P2860
Therapeutic drug monitoring of antiepileptic drugs by use of saliva.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Therapeutic drug monitoring of antiepileptic drugs by use of saliva.
@ast
Therapeutic drug monitoring of antiepileptic drugs by use of saliva.
@en
Therapeutic drug monitoring of antiepileptic drugs by use of saliva.
@nl
type
label
Therapeutic drug monitoring of antiepileptic drugs by use of saliva.
@ast
Therapeutic drug monitoring of antiepileptic drugs by use of saliva.
@en
Therapeutic drug monitoring of antiepileptic drugs by use of saliva.
@nl
prefLabel
Therapeutic drug monitoring of antiepileptic drugs by use of saliva.
@ast
Therapeutic drug monitoring of antiepileptic drugs by use of saliva.
@en
Therapeutic drug monitoring of antiepileptic drugs by use of saliva.
@nl
P1476
Therapeutic drug monitoring of antiepileptic drugs by use of saliva.
@en
P2093
Dave J Berry
Philip N Patsalos
P356
10.1097/FTD.0B013E31827C11E7
P577
2013-02-01T00:00:00Z